Biotech China 2014
4th DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE
The Houstonian Hotel, Club & Spa
111 North Post Oak Lane
Houston, Texas
http://www.worldeventsforum.com/addf/2010/html/program.html
4th DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE

Schedule of Presentations:

Monday, February 1, 2010
07:45:00 Registration & Continental Breakfast
08:30:00 Overview of Drug Discovery for Neurodegenerative Disease Howard Fillit
08:40:00 Stem Cells to Accelerate Drug Discovery for Neurodegenerative Disease Lee Rubin
08:55:00 I. Basics of Medicinal Chemistry D Martin Watterson
09:00:00 Overview: Medicinal Chemistry Rules of Thumb, Myths and Realities in CNS Drug Discovery D Martin Watterson
09:30:00 Designing Small Molecules with Increased Potential for CNS Penetration Laura Chico
10:10:00 Synthetic Chemistry Essentials for Biologists Heather Behanna
10:40:00 Q&A
10:50:00 BREAK
11:05:00 II. In-vitro Testing: Early Phases of Drug Discovery Marcie Glicksman
11:05:00 Session Overview Marcie Glicksman
11:10:00 Developing Relevant High-Throughput Assays for the Identification of Potential Drug Candidates Marcie Glicksman
11:35:00 Q&A
11:45:00 Role of In Vitro Models in Drug Discovery for Neurodegenerative Disease Linda Van Eldik
12:10:00 Q&A
12:20:00 LUNCH
13:20:00 In Vitro Toxicity Testing: What, Why & How Karen L. Steinmetz
13:35:00 Q&A
13:45:00 III. Pre-Clinical Proof-of-Concept & Development Edward Spack
13:45:00 Session Overview Edward Spack
13:50:00 Requirements for a Lead Compound to Become a Clinical Candidate Nancy G. Wehner
14:15:00 Q&A
14:25:00 Behavioral Testing in Neurodegenerative Disease Taleen Hanania
14:50:00 Q&A
15:00:00 BREAK
15:15:00 Regulatory Requirements & Strategy Joy A. Cavagnaro
15:40:00 Q&A
15:50:00 The Basics of Pre-Clinical Development Edward Spack
16:00:00 Q&A
16:10:00 Closing Remarks Howard Fillit
16:20:00 NETWORKING RECEPTION
Tuesday, February 2, 2010
08:00:00 Continental Breakfast
08:30:00 Welcome & Opening Remarks Suzana Petanceska
08:35:00 IV. Issues in Technology Transfer: Interactions and Intellectual Property Kathleen Denis
08:35:00 Session Overview Kathleen Denis
08:40:00 Working Effectively with Your TTO: Roles and Responsibilities Kathleen Denis
09:10:00 Q&A
09:20:00 Intellectual Property 101: A Primer For Investigators Colin G. Sandercock
09:50:00 Q&A
10:00:00 Creating Relationships with Industry: Consulting, Research, MTA's and Patent Licensing Louis Berneman
10:30:00 Q&A
10:40:00 BREAK
10:55:00 Should You Start a Biotechnology Company? John S. Swartley
11:25:00 Q&A
11:35:00 What Companies Look for in a Licensing Partner Susan P. Rohrer
12:00:00 LUNCH
12:00:00 Q&A
13:00:00 Session Overview Todd Sherer
13:00:00 V. Case Studies Todd Sherer
13:10:00 Track 1: Target Validation to Lead Optimization AD Case Study Howard Fillit, Marcie Glicksman, D Martin Watterson, Frank Longo
13:10:00 Track 2: Pre-Clinical to IND Enabling PD Case Study Damian Brunner, Todd Sherer, Lorenzo Refolo, Colleen Niswender
13:10:00 Track 3: Developing Biologics MS Case Study Keith F. Martin, Tim Coetzee, Edward Spack, Nancy G. Wehner
14:10:00 Session Overview Lorenzo Refolo
14:10:00 VI. Resources and Services For Advancing Drug Discovery Lorenzo Refolo
14:15:00 How to Outsource Early Drug Discovery Sitta Sittampalam
14:40:00 Q&A
14:50:00 Resources at the National Institute of Health William Matthew
15:15:00 Q&A
15:25:00 Types of Academic Drug Discovery Programs D Martin Watterson
15:50:00 Q&A
16:00:00 Foundation Resources:
16:05:00 1 Venture Philanthropy Howard Fillit
16:15:00 2 Other Philanthropic Approaches Tim Coetzee
16:20:00 3 Funding and other challenges for rare diseases Leticia M. Toledo-Sherman
16:30:00 Q&A
16:40:00 Closing Remarks Howard Fillit
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.